But are the vaccines we currently have able to deal with the newest COVID variants? The current COVID vaccines are all based ...
MDA Notice (Malaysian) SK bioscience wins first authorization for home-grown COVID vaccine in South Korea The Korean Ministry ...
Chemicals group Wacker Chemie has commissioned construction firm Exyte to build a plant for mRNA components, a medical ...
Interview - During The Kigali Summit on Malaria and Neglected Tropical Diseases (NTDs) hosted by Rwanda, leaders reflected on the Kigali summit and made commitments to work towards ending the epidemic ...
In line with the FDA's recommendation for the fall vaccine program, Novavax says it's working on an omicron-based COVID-19 vaccine.
CNET19h
Allied Market Research published a report, titled, "Vaccines Market by Technology Type (Recombinant & Conjugate Vaccines, Live Attenuated Vaccines, Inactivated Vaccines, Toxoid Vaccines, and Other ...
NEW YORK  - Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced positive data evaluating the safety, tolerability, and immunogenicity of two Omicron-adapted COVID-19 vaccine ...
The Central Epidemic Command Center (CECC) on Wednesday announced an expansion of the second COVID-19 vaccine booster shot program, doubling the number of eligible groups to eight. Previously eligible ...
Coronavirus vaccines tweaked to include the Omicron variant strain can improve protection when used as a booster, the European Medicines Agency and other global health regulators said on Friday.
You can also get the latest COVID-19 news delivered to your inbox weeknights at 7 p.m. by subscribing to our newsletter here.
Zacks.com announces the list of stocks featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss t ...
Pfizer Inc and partner BioNTech SE said on Wednesday they signed a $3.2 billion deal with the U.S. government for 105 million ...